logo

Bioscrip Inc. (BIOS)



Trade BIOS now with
  Date
  Headline
7/22/2019 9:10:47 AM ISS, Glass Lewis Recommend BioScrip Stockholders Vote For Transaction Proposals On Proposed Merger With Option Care
3/15/2019 7:17:51 AM BioScrip Q4 Loss Per Share $0.12 Vs Loss $0.18 Last Year
11/6/2018 8:16:41 AM BioScrip Q3 Net Revenue Of $181.0 Mln Vs $198.7 Mln Last Year
10/22/2018 4:33:57 PM BioScrip Appoints John McMahon As Chief Accounting Officer
8/7/2018 8:07:12 AM BioScrip Q2 Net Loss From Cont Ops $15.1 Mln, Net Revenue $175.8 Mln
7/30/2018 8:33:05 AM BioScrip Appoints Leslie McIntosh As Chief Human Resources Officer
7/10/2018 8:32:32 AM BioScrip Appoints Richard Denness As Chief Commercial Officer
5/10/2018 8:33:58 AM BioScrip Q1 Loss Per Share $0.12 Vs Loss $0.18 Last Year
3/26/2018 6:34:21 AM BioScrip Timely Files Annual Form 10-K, Provides Update On Immaterial Financial Statement Corrections
3/8/2018 8:21:04 AM BioScrip May Delay Filing Of Annual Report Due To Accounting Issue
3/8/2018 8:13:39 AM BioScrip Q4 Net Loss From Cont Ops $1.2 Mln, Adjusted EBITDA $16.8 Mln
1/8/2018 8:24:02 AM BioScrip Reports Availability Of HEMLIBRA For Hemophilia Patients
  
 
>